Raltegravir 600mg tablets
NHS hospitals in England used £22,285,265 of indicative cost of Raltegravir 600mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is down 23.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Raltegravir 600mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Raltegravir 600mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Chelsea & Westminster Hospital Nhs Ft | £2,828,431 |
| Manchester University Nhs Ft | £2,405,942 |
| Guy's & St Thomas' Nhs Foundation Trust | £1,438,489 |
| King's College Hpl Nhs Foundation Trust | £1,268,912 |
| Ctrl & N W London Nhs Foundation Trust | £962,856 |
| Royal Free London Nhs Foundation Trust | £885,623 |
| Western Sussex Hospitals Nhs Found Trust | £861,026 |
| Imperial College Healthcare Nhs Trust | £778,243 |
| Barts Health Nhs Trust | £661,878 |
| University College London Foundation Tr | £632,866 |
The primary-care picture
Raltegravir is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Raltegravir medicine page.